Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Kozlowski

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
International Journal of Pharmaceutics: X|March 28, 2024
A network of regulatory innovations to improve FDA quality assessments of human drug applicationsRussie Tran, Grace Fraser, Adam C Fisher, et al.
International Journal of Pharmaceutics|May 2, 2022
An audit of pharmaceutical continuous manufacturing regulatory submissions and outcomes in the USAdam C Fisher, William Liu, Andreas Schick, et al.
Nature Reviews. Drug Discovery|July 20, 2007
The FDA's assessment of follow-on protein products: a historical perspectiveJanet Woodcock, Joseph Griffin, Rachel Behrman, et al.
Journal of Pharmaceutical Sciences|August 16, 2008
Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product qualityJohn F Carpenter, Theodore W Randolph, Wim Jiskoot, et al.
JAMA Internal Medicine|October 25, 2016
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service MedicareCunlin Wang, Robert Kane, Mark Levenson, et al.
The New England Journal of Medicine|December 5, 2008
Outbreak of adverse reactions associated with contaminated heparinDavid B Blossom, Alexander J Kallen, Priti R Patel, et al.
Vaccine|May 27, 2023
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccinationZhao-Hua Zhou, Margaret M Cortese, Jia-Long Fang, et al.
The AAPS Journal|April 5, 2015
Advancing Product Quality: a Summary of the Inaugural FDA/PQRI ConferenceLawrence X Yu, Jeffrey Baker, Susan C Berlam, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
International Journal of Pharmaceutics: X|March 28, 2024
A network of regulatory innovations to improve FDA quality assessments of human drug applicationsRussie Tran, Grace Fraser, Adam C Fisher, et al.
International Journal of Pharmaceutics|May 2, 2022
An audit of pharmaceutical continuous manufacturing regulatory submissions and outcomes in the USAdam C Fisher, William Liu, Andreas Schick, et al.
Nature Reviews. Drug Discovery|July 20, 2007
The FDA's assessment of follow-on protein products: a historical perspectiveJanet Woodcock, Joseph Griffin, Rachel Behrman, et al.
Journal of Pharmaceutical Sciences|August 16, 2008
Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product qualityJohn F Carpenter, Theodore W Randolph, Wim Jiskoot, et al.
JAMA Internal Medicine|October 25, 2016
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service MedicareCunlin Wang, Robert Kane, Mark Levenson, et al.
The New England Journal of Medicine|December 5, 2008
Outbreak of adverse reactions associated with contaminated heparinDavid B Blossom, Alexander J Kallen, Priti R Patel, et al.
Vaccine|May 27, 2023
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccinationZhao-Hua Zhou, Margaret M Cortese, Jia-Long Fang, et al.
The AAPS Journal|April 5, 2015
Advancing Product Quality: a Summary of the Inaugural FDA/PQRI ConferenceLawrence X Yu, Jeffrey Baker, Susan C Berlam, et al.
Pageof 4